These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Translocation (1;11)(q23;p15), a novel simple variant of translocation (7;11)(p15;p15), in a patient with AML (M2) accompanied by non-Hodgkin lymphoma and gastric cancer. Hatano Y; Miura I; Kume M; Miura AB Cancer Genet Cytogenet; 2000 Feb; 117(1):19-23. PubMed ID: 10700860 [TBL] [Abstract][Full Text] [Related]
45. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Megonigal MD; Cheung NK; Rappaport EF; Nowell PC; Wilson RB; Jones DH; Addya K; Leonard DG; Kushner BH; Williams TM; Lange BJ; Felix CA Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2814-9. PubMed ID: 10706619 [TBL] [Abstract][Full Text] [Related]
47. Etoposide and secondary haematological malignancies: coincidence or causality? Zulian GB; Jotterand Bellomo M; Cabrol C; Beris P; Mermillod B; Alberto P Ann Oncol; 1993 Aug; 4(7):559-66. PubMed ID: 8395872 [TBL] [Abstract][Full Text] [Related]
48. [Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma]. Miyata A; Deguchi S; Fujita M; Kikuchi T; Honda K Rinsho Ketsueki; 1996 May; 37(5):448-51. PubMed ID: 8691593 [TBL] [Abstract][Full Text] [Related]
49. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide. Chen CL; Fuscoe JC; Liu Q; Pui CH; Mahmoud HH; Relling MV J Natl Cancer Inst; 1996 Dec; 88(24):1840-7. PubMed ID: 8961974 [TBL] [Abstract][Full Text] [Related]
50. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Pedersen-Bjergaard J; Andersen MK; Christiansen DH; Nerlov C Blood; 2002 Mar; 99(6):1909-12. PubMed ID: 11877259 [TBL] [Abstract][Full Text] [Related]
51. Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment. Bower M; Parry P; Gibbons B; Amess J; Lister TA; Young BD; Evans GA Leukemia; 1994 Feb; 8(2):226-9. PubMed ID: 8309246 [TBL] [Abstract][Full Text] [Related]
52. Acute lymphoid leukemia with t(4;11) (q21;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase II. Pedersen-Bjergaard J Leuk Res; 1992 Aug; 16(8):733-5. PubMed ID: 1326684 [No Abstract] [Full Text] [Related]
53. Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review. Shimada N; Ohno N; Tanosaki R; Fuji S; Suzuki Y; Yuji K; Uchimaru K; Tojo A Intern Med; 2017; 56(14):1879-1884. PubMed ID: 28717086 [TBL] [Abstract][Full Text] [Related]
54. Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints. Atlas M; Head D; Behm F; Schmidt E; Zeleznik-Le NH; Roe BA; Burian D; Domer PH Leukemia; 1998 Dec; 12(12):1895-902. PubMed ID: 9844920 [TBL] [Abstract][Full Text] [Related]
57. Involvement of 11p15 and 3q21q26 in therapy-related myeloid leukemia (t-ML) in children. Case reports and review of the literature. Stark B; Jeison M; Shohat M; Goshen Y; Vogel R; Cohen IJ; Yaniv I; Kaplinsky C; Zaizov R Cancer Genet Cytogenet; 1994 Jul; 75(1):11-22. PubMed ID: 8039158 [TBL] [Abstract][Full Text] [Related]
58. Therapy-related acute myeloid leukemia with t(10;11)(q23;p15) following successful chemotherapy for acute promyelocytic leukemia with t(15;17)(q22;q21). Sawada H; Morimoto H; Wake A; Yamasaki Y; Izumi Y Int J Hematol; 1999 Jun; 69(4):270-1. PubMed ID: 10407587 [No Abstract] [Full Text] [Related]